Aaron Cumpston - Concepedia

Author

Aaron Cumpston

West Virginia University ORCID

Also Known As

A Cumpston, A D Cumpston, A. Cumpston, A.D. Cumpston, Aaron Cumpston, Cumpston, Aaron

102

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

West Virginia University West Virginia University Hospitals Medical College of Wisconsin Augusta University Health King Faisal Specialist Hospital & Research Centre

About

Aaron Cumpston is an author at West Virginia University specializing in medicine, hematology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	527
2	Health Sciences	4	4	138
3	Blood Transplantation	4	4	64
4	Allergy	1	1	30
5	Cell Biology	1	1	33

Aaron Cumpston

Publications

Citations

H-Index

Page 1

	Year	Citations
Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis Carla Casulo, Jonathan W. Friedberg, Kwang Woo Ahn, Biology of Blood and Marrow Transplantation	2017	136
Impact of alcohol-impregnated port protectors and needleless neutral pressure connectors on central line–associated bloodstream infections and contamination of blood cultures in an inpatient oncology unit Michael Sweet, Aaron Cumpston, Frank Briggs, American Journal of Infection Control Inpatient Oncology UnitAlcohol-impregnated Port ProtectorsPatient SafetyBloodstream InfectionsMedicine	2012	80
Intermediate-Dose versus Low-Dose Cyclophosphamide and Granulocyte Colony-Stimulating Factor for Peripheral Blood Stem Cell Mobilization in Patients with Multiple Myeloma Treated with Novel Induction Therapies Mehdi Hamadani, Samith T. Kochuparambil, Salman Osman, Biology of Blood and Marrow Transplantation	2012	71
Superior Serum Concentrations with Posaconazole Delayed-Release Tablets Compared to Suspension Formulation in Hematological Malignancies Aaron Cumpston, Ryan Caddell, Alexandra Shillingburg, Antimicrobial Agents and Chemotherapy Pharmaceutical ScienceClinical MycologyPharmacotherapyHematological MalignanciesMetronomic Therapy	2015	67
The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit Michael Craig, Aaron Cumpston, Gerry Hobbs, Bone Marrow Transplantation Transplantation UnitAntibioticsHealth SciencesCycling AntibioticsHealthcare-associated Infection	2007	67
A post-marketing evaluation of posaconazole plasma concentrations in neutropenic patients with haematological malignancy receiving posaconazole prophylaxis Alexander M. Bryant, Douglas Slain, Aaron Cumpston, International Journal of Antimicrobial Agents Hematological MalignancyMedicinePosaconazole ProphylaxisHematologyPosaconazole Plasma Concentrations	2011	60
Comparable efficacy and lower cost of PBSC mobilization with intermediate-dose cyclophosphamide and G-CSF compared with plerixafor and G-CSF in patients with multiple myeloma treated with novel therapies Farrukh T. Awan, Samith T. Kochuparambil, Debbie Falconer, Bone Marrow Transplantation Hematological MalignancyOncologyPbsc MobilizationMetronomic TherapyImmunology	2013	49
Sibling Donor and Recipient Immune Modulation With Atorvastatin for the Prophylaxis of Acute Graft-Versus-Host Disease Mehdi Hamadani, Laura F. Gibson, Scot C. Remick, Journal of Clinical Oncology	2013	45
Azacitidine-associated Sweet’s syndrome Hannah B. Trickett, Aaron Cumpston, Michael P. Craig American Journal of Health-System Pharmacy	2012	37
Hematopoietic progenitor cell mobilization with “just-in-time” plerixafor approach is a cost-effective alternative to routine plerixafor use Lauren Veltri, Aaron Cumpston, Alexandra Shillingburg, Cytotherapy Plerixafor UseRadiation OncologyMedicineStem Cell MobilizationHematology	2015	33

Page 1